Peptide library
A growing reference of research peptides currently of interest in scientific study. For research use only.
AOD-9604
Modified hGH fragment (176–191) studied for fat metabolism without affecting glucose or IGF-1.
BPC-157
Body Protection Compound studied for accelerated tissue repair, gut integrity, and tendon recovery.
Cagrilintide
Long-acting amylin analog investigated for appetite regulation and weight management, often paired with GLP-1 agonists.
CJC-1295 with DAC
Long-acting GHRH analog with Drug Affinity Complex, designed to sustain elevated GH and IGF-1 levels.
CJC-1295 (No DAC) / Mod GRF 1-29
Short-acting GHRH analog (Mod GRF 1-29) studied for pulsatile GH release with rapid clearance.
Epithalon
Tetrapeptide investigated for telomerase activation, sleep regulation, and longevity.
EPO Zeta (Erythropoietin)
Recombinant erythropoietin biosimilar studied for red blood cell production and oxygen-carrying capacity.
Follistatin (FST-344)
Glycoprotein investigated for myostatin inhibition, muscle growth, and tissue regeneration.
FOXO4-DRI
Senolytic peptide investigated for selective elimination of senescent cells.
GDF-8 Inhibitor (Myostatin)
Growth Differentiation Factor 8 research peptide studied for myostatin pathway modulation.
GHK-Cu (Copper Peptide)
Copper-binding tripeptide widely studied for skin remodeling, hair growth, and tissue regeneration.
GHRP-2
Growth Hormone Releasing Peptide-2 studied for potent, pulsatile GH release.
Gonadorelin (GnRH)
Synthetic gonadotropin-releasing hormone studied for LH and FSH stimulation.
Hexarelin
Synthetic hexapeptide ghrelin mimetic studied for strong GH release and cardiac research.
HGH 191aa (Somatropin)
Recombinant 191-amino-acid human growth hormone studied as the reference somatotropin standard.
HGH Fragment 176-191
C-terminal hGH fragment studied for fat-loss effects without growth or insulin-axis impact.
HMG (Menotropin)
Human Menopausal Gonadotropin combining LH and FSH activity for reproductive research.
IGF-1 LR3
Long Arg3 IGF-1 analog with extended half-life, studied for anabolic and tissue-growth pathways.
IGF-1 DES (1-3)
N-terminally truncated IGF-1 variant studied for localized, short-acting anabolic effects.
Ipamorelin
Selective ghrelin mimetic with minimal impact on cortisol or prolactin.
Kisspeptin-10
Decapeptide regulator of GnRH neurons, studied for reproductive axis activation.
KPV
C-terminal α-MSH tripeptide studied for anti-inflammatory and gut-healing properties.
Mazdutide
Dual GLP-1 / glucagon receptor agonist investigated for metabolic and weight outcomes.
MOTS-c
Mitochondrial-derived peptide studied for metabolic regulation and exercise-mimetic effects.
Melanotan I (MT-1)
α-MSH analog studied for melanogenesis with greater receptor selectivity than MT-2.
Melanotan II (MT-2)
Cyclic α-MSH analog studied for pigmentation and broad melanocortin receptor activation.
NAD+
Nicotinamide adenine dinucleotide coenzyme studied for cellular energy and longevity research.
PEG-MGF
PEGylated Mechano Growth Factor with extended half-life, studied for muscle repair and hypertrophy.
PT-141 (Bremelanotide)
Melanocortin receptor agonist investigated for libido and sexual function in both sexes.
Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist investigated for substantial weight reduction.
Selank
Synthetic anxiolytic peptide based on tuftsin, studied for stress modulation without sedation.
Semaglutide
GLP-1 receptor agonist studied for glycemic control, appetite regulation, and weight loss.
Semax
Heptapeptide ACTH analog investigated for neuroprotection, focus, and cognitive enhancement.
Sermorelin (GHRH 1-29)
Bioactive 29-amino-acid GHRH fragment studied for natural, pulsatile GH stimulation.
SS-31 (Elamipretide)
Mitochondria-targeted tetrapeptide studied for cardiolipin stabilization and mitochondrial function.
Survodutide
Dual GLP-1 / glucagon receptor agonist investigated for weight loss and MASH/NASH research.
Tesamorelin
Stabilized GHRH analog studied for visceral fat reduction and IGF-1 elevation.
Tirzepatide
Dual GIP / GLP-1 receptor agonist investigated for superior metabolic and weight outcomes.
Triptorelin
Long-acting GnRH agonist studied for HPG axis modulation through receptor downregulation.